CTOs on the Move


 
SynGen advances regenerative medicine and other emerging applications for high-value cells by providing researchers, clinicians and manufacturers with innovative, robust systems that improve the recovery, purity and viability of stem and other clinically important cells from umbilical cord blood, peripheral blood, bone marrow, and cell culture.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.syngeninc.com
  • 2125 19th St Suite 120
    Sacramento, CA USA 95818
  • Phone: 916.706.0923

Executives

Name Title Contact Details

Similar Companies

Cherry Optical Inc

Cherry Optical Inc is a Melvindale, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CCA Industries

CCA Industries, Inc. (CCA) is engaged in the health and beauty aids business, selling numerous products in several health and beauty aids and cosmeceutical categories.

Anthem Incorporated

At Anthem, Inc., we believe that our health connects us all. So we focus on being a valued health partner and delivering quality products and services that give members access to the care they need. With more than 67 million people served by our affiliated companies including approximately 37 million enrolled in our family of health plans, we can make a real difference to meet the needs of our diverse customers.

Mobility Center Of Va

Mobility Center Of Va is a Richmond, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Monarch Medical Technologies

Monarch Medical Technologies is a digital health company committed to helping hospitals and health systems deliver optimal glycemic management for critical care and non-critical care patients alike. Insulin dosing has always been a daunting and time-intensive task, but now that burnout and staffing constraints have reached record highs, never have the associated risks and challenges been more acute. Add the impacts of new CMS measures for hyperglycemia and hypoglycemia, and you have the perfect storm. Our FDA-cleared EndoTool® Glucose Management System is designed specifically to displace traditional manual methods of insulin dosing with an intuitive and easy-to-use software application that integrates seamlessly with your EMR. This pioneering clinical decision support platform offers both intravenous and subcutaneous modalities, and has been shown to safely and reliably achieve and maintain target glucose goals. Specialized features help clinicians address the complexities surrounding diabetic ketoacidosis (DKA), hyperosmolar hyperglycemic nonketotic syndrome (HHS), gestational diabetes, kidney function, residual insulin, and presence of steroids.